Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Blis Technologies (BLT) / FY23

Result released25 May 2023·Annolyse analysis published22 April 2026

Loss narrowed 50.1% on 14.2% revenue growth, cash halved to $4.3m

Operating cash flow flipped positive and H2 turned profitable, yet the cash balance fell $4.2m versus only $0.1m of OCF — a reconciliation gap that

Healthcare / Biotechnology

BLT revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY23 revenue trajectory was $4.3m.

BLT operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY23 operating cash flow was $0.35m.

BLT NPAT trajectory

Statutory profit after tax across covered periods.

↗
Loading chart...
HY23 npat trajectory was -$1.7m.

BLT net debt

Borrowings less cash across covered periods.

↗
Loading chart...
HY23 net debt was -$8.7m.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 17 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$20.5m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

29.24x

i

Recent market cap compared with trailing earnings.

EPS

0.00

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not meaningful without positive comparable earnings growth.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

1.57x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
25 May 2023
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY23 vs FY22

Revenue

$10.2m

+14.2% ↑ vs $9m

EBITDA

—

— vs −$2.1m

Net profit after tax

−$1.3m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$0.11m

+104.6% ↑ vs −$2.3m

Declared dividend per share

0.0c

flat vs 0.0c

Profit before tax

−$1.3m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$4.3m

-49.9% ↓ vs $8.5m

Total assets

$12.8m

-9.4% ↓ vs $14.1m

Analysis ofBLT FY23·Result released25 May 2023·Annolyse analysis published22 April 2026

What changed

Blis delivered revenue of $10.2m, up 14.2%, and narrowed its net loss by 50.1% to $1.4m

Operating cash flow flipped from an outflow of $2.3m to a small inflow of $0.1m, and the FY22 EBITDA loss of $2.1m is no longer disclosed on a comparable basis in the supplied excerpts.

The second-half shape is the more important movement within the year. With HY23 NPAT of -$1.7m and full-year NPAT of -$1.4m, the implied H2 NPAT was approximately +$0.3m, consistent with the release headline of "a profitable second half year."

Despite the OCF flip, cash and equivalents fell from $8.5m to $4.3m, a 49.9% decline. Equity fell 10.8% to $10.8m, gross borrowings went to zero, and the balance sheet remains net cash by $4.3m.

What matters

The cash-balance halving is the most material issue

Reported OCF was +$0.1m and capex was only -$0.1m, producing pre-lease free cash flow of about +$0.06m. Yet cash fell by $4.2m. The supplied data does not reconcile the gap, which means the on-paper return to operating cash generation overstates the period's actual liquidity outcome. For a company with $4.3m of cash and no revolver disclosed, that gap is the dominant question on the result.

The H2 inflection is real but small. An implied H2 NPAT of roughly +$0.3m is the first profitable half since the strategy reset announced in July 2022, and it is driven by both higher revenue ($5.9m implied in H2 versus $4.3m in H1) and the lower cost base flagged in management commentary. This matters because it is the first evidence the B2B-and-partnerships strategy can clear breakeven, but the half is too small to demonstrate that profitability is sustainable rather than timing-assisted.

Working capital tightened modestly. Receivable days fell from 68.8 to 51.6 and inventory days from 31.8 to 26.2, releasing roughly $0.3m of operating working capital. That helped OCF but is not a repeatable lever — debtor and inventory balances are now low in absolute terms, so further cash release from this source is limited.

Expectations

No forward targets or quantified guidance are supplied in the release excerpts, so the result has to be judged against the strategy reset itself: returning to "a sustained profitable trading position" via B2B revenue growth and partnerships

The H2 profitability and the 14.2% revenue growth are directionally consistent with that goal.

The second-half-weighted shape (HY23 contributed only 41.9% of full-year revenue) is a meaningful read for FY24: it sets a higher exit run-rate but also means that any softening in the H2 partner-driven revenue would land disproportionately. Without disclosed forward work or partner contract terms, the durability of the H2 step-up cannot be assessed from this release.

Quality of result

The earnings improvement is clean at the reported-profit level: there is no tax distortion (effective tax rate 0.0% in both periods), no discontinued operation, and PBT and NPAT growth are identical at 50.1%

Non-recurring items are not flagged. To that extent, the 50.1% loss reduction reflects genuine operating progress, supported by 14.2% revenue growth and lower opex implied by the EBITDA-loss to small-NPAT-loss compression.

The cash quality is materially weaker than the P&L quality. FCF-to-NPAT of -4.1% understates the issue, because the cash balance fell $4.2m while pre-lease FCF was only +$0.06m. Possible drains — lease payments, term-deposit reclassifications, or other investing/financing flows — are not surfaced in the supplied excerpts. Until that bridge is explained, the H2 profitability print should be treated as an early signal rather than confirmation that the business is self-funding.

Unresolved

Open questions

What specifically drove the $4.2m decline in cash when operating cash flow was only +$0.1m and capex was -$0.1m?
How much of the implied H2 NPAT of $0.3m is attributable to recurring B2B partner revenue versus one-off licensing or milestone payments?
Why is FY23 EBITDA not disclosed alongside the FY22 comparable of -$2.1m in the supplied release excerpts?
What is the runway implied by the current $4.3m cash balance against the expected H1 FY24 cost base?
Will the receivable-days improvement from 68.8 to 51.6 hold as B2B partner mix grows, or does it reflect period-end timing?

This briefing cannot assess the cash bridge between reported OCF and the $4.2m fall in cash and equivalents, which is the single most important quality question on the result.

Chat

Ask about BLT FY23

Ask follow-up questions about Blis Technologies's FY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about BLT FY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Blis Technologies's FY23 result.

What specifically drove the $4.2m decline in cash when operating cash flow was only +$0.1m and capex was -$0.1m?Why does "The cash-balance halving is the most material issue" matter?How strong was the cash and earnings quality in FY23?What should I watch next for BLT after FY23?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

BLIS Annual Report FY23

FY23 / financial report↗

Financial Results Announcement

FY23 / results announcement↗

Prior comparable period

Financial Results Announcement

FY22 / results announcement↗

Financial Results Announcement

FY22 / results release↗

FY22 Annual Report

FY22 / financial report↗

Interim context

Financial results announcement

HY23 / results announcement↗

Financial results announcement

HY23 / results release↗

Half year report 30 September 2022

HY23 / financial report↗

Related insights

Cross-company views selected from the metrics in this briefing.

Dividend coverage and payout pressure

Dividend payout versus NPAT is 0.0%.

→

Revenue growth context

Revenue growth was 14.2% for this reporting period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 0.0pp.

→

Working-capital pressure

Inventory days were 26 days, -6 days versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when BLT publishes next

Get the next Blis Technologies briefing and related NZX reporting-season updates by email.